Net Sales at Rs 522.95 crore in March 2023 down 10.55% from Rs. 584.62 crore in March 2022. Quarterly Net Profit at Rs. 49.28 crore in March 2023 down 18.9% from Rs. 60.76 crore in March 2022. EBITDA stands at Rs. 78.80 crore in March 2023 down 0.38% from Rs. 79.10 crore in March 2022. Gokaldas Export EPS has decreased to Rs. 8.13 in March 2023 from Rs. 10.30 in March 2022.
GEORGE VARUGHESE
Non–Executive Independent Director
Mr. George Varughese is the CEO and Managing Director of Alvarez and Marsal Securities, which is the broker-dealer and investment banking unit of Alvarez and Marsal in the USA. He is based in New York.
Mr. Varughese has completed Mergers and Acquisitions, Financing and Restructuring transactions in various industries over the last 35 years. He is also the Chairman of the Opinion committee of the firm.
Before joining Alvarez and Marsal, he was partner in Merchant Banking at Credit Suisse. Previously, he was the Managing Director of DLJ Merchant Banking and established the India office for DLJ, and supervised the Asia business.
He also has served as the Professor of Finance at the Indian Institute on Management Bangalore. Currently, in addition to his duties at Alvarez and Marsal, he teaches course on Mergers and Acquisitions and Restructuring at New York University. He serves on the Board of H2 Health, a Healthcare company in the USA and is also on the Board of Vellore Foundation and Birch Family Services. He is chairman of the audit committee at H2 Health and Vellore Foundation. He also is a Member of the Investment Committee of the Fund and the co-investment program of Quilvest.
Mr. Varughese is a Bachelor in Arts from Harvard University and MBA from Stanford University.
